Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

t-AML

A type of acute myeloid leukemia (AML) that is caused by previous treatment with chemotherapy or radiation therapy. t-AML is an aggressive (fast-growing) cancer in which there are too many myeloblasts (immature white blood cells) in the blood or bone marrow. t-AML usually occurs within 7 years after treatment. It is more common in adults. Also called therapy-related acute myeloid leukemia.
Search NCI's Dictionary of Cancer Terms